| Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin AH Verma, JP Richardson, C Zhou, BM Coleman, DL Moyes, J Ho, ... Science immunology 2 (17), eaam8834, 2017 | 178 | 2017 |
| Expression of RXFP1 is decreased in idiopathic pulmonary fibrosis. Implications for relaxin-based therapies J Tan, JR Tedrow, JA Dutta, B Juan-Guardela, M Nouraie, Y Chu, ... American journal of respiratory and critical care medicine 194 (11), 1392-1402, 2016 | 58 | 2016 |
| An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis K Ramani, S Pawaria, K Maers, AR Huppler, SL Gaffen, PS Biswas Journal of leukocyte biology 96 (3), 463-472, 2014 | 54 | 2014 |
| Interleukin-17: Friend or foe in organ fibrosis K Ramani, PS Biswas Cytokine 120, 282-288, 2019 | 50 | 2019 |
| The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney K Ramani, AV Garg, CV Jawale, HR Conti, N Whibley, EK Jackson, ... PLoS pathogens 12 (11), e1005952, 2016 | 42 | 2016 |
| Complement component C5a permits the coexistence of pathogenic Th17 cells and type I IFN in lupus S Pawaria, K Ramani, K Maers, Y Liu, LP Kane, MC Levesque, PS Biswas The Journal of Immunology 193 (7), 3288-3295, 2014 | 31 | 2014 |
| Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection K Ramani, CV Jawale, AH Verma, BM Coleman, JK Kolls, PS Biswas JCI insight 3 (9), 2018 | 28 | 2018 |
| Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12 KDJ Tan J, Tedrow JR, Nouraie M, Dutta JA, Miller DT, Li X, Yu S, Chu Y ... Journal of Immunology, 2017 | 27 | 2017 |
| IL-17 receptor signaling negatively regulates the development of tubulointerstitial fibrosis in the kidney K Ramani, RJ Tan, D Zhou, BM Coleman, CV Jawale, Y Liu, PS Biswas Mediators of inflammation 2018, 2018 | 26 | 2018 |
| Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease CV Jawale, K Ramani, D Li, BM Coleman, RS Oberoi, S Kupul, L Lin, ... Science translational medicine 12 (548), eaay5691, 2020 | 23 | 2020 |
| Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice K Ramani, PS Biswas Clinical immunology 162, 31-36, 2016 | 23 | 2016 |
| Emerging roles of the Th17/IL-17-axis in glomerulonephritis K Ramani, PS Biswas Cytokine 77, 238-244, 2016 | 20 | 2016 |
| Type I interferon and T helper 17 cells co‐exist and co‐regulate disease pathogenesis in lupus patients PS Biswas, R Aggarwal, MC Levesque, K Maers, K Ramani International journal of rheumatic diseases 18 (6), 646-653, 2015 | 18 | 2015 |
| Regulation of peripheral inflammation by a non-viable, non-colonizing strain of commensal bacteria K Ramani, T Cormack, ANR Cartwright, A Alami, P Parameswaran, ... Frontiers in Immunology 13, 768076, 2022 | 8 | 2022 |
| RTEC-intrinsic IL-17–driven inflammatory circuit amplifies antibody-induced glomerulonephritis and is constrained by Regnase-1 DD Li, R Bechara, K Ramani, CV Jawale, Y Li, JK Kolls, SL Gaffen, ... JCI insight 6 (13), 2021 | 4 | 2021 |
| Uremia coupled with mucosal damage predisposes mice with kidney disease to systemic infection by commensal Candida albicans CV Jawale, DD Li, K Ramani, L Lin, K Li, B Methe, PS Biswas ImmunoHorizons 5 (1), 16-24, 2021 | 4 | 2021 |
| Clinical translation of anti-inflammatory effects of Prevotella histicola in Th1, Th2, and Th17 inflammation A Itano, D Maslin, K Ramani, G Mehraei, N Carpenter, T Cormack, ... Frontiers in Medicine 10, 1070433, 2023 | 3 | 2023 |
| Antibody-induced glomerulonephritis pathology is amplified by RTEC-intrinsic IL-17 signaling and restrained by the endoribonuclease Regnase-1 D Li, RR Bechara, K Ramani, CV Jawale, Y Li, JK Kolls, SL Gaffen, ... BioRXiv 425972, 2021, 2021 | 2 | 2021 |
| Orally-administered EDP1815, a single strain of Prevotella histicola, has potent systemic anti-inflammatory effects in Type 1, Type 2, and Type 3 inflammatory models A Itano, T Cormack, K Ramani, K Barth, I Wang, A Mukherjee, ... Proceedings of the 29th European Academy of Dermatology and Venereology …, 2020 | 2 | 2020 |
| Treatment with an orally delivered non-replicating, non-colonizing strain of Veillonella parvula resolves systemic inflammation in murine models of disease K Ramani, T Cormack, A Cartwright, A Alami, S Argueta, D Raghunathan, ... The Journal of Immunology 208 (1_Supplement), 113.08-113.08, 2022 | | 2022 |
